Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 1999;30:1687-1694

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calabresi, P.
Right arrow Articles by Hurn, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calabresi, P.
Right arrow Articles by Hurn, P. D.
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Embolic stroke
Right arrow Other Stroke Treatment - Medical

(Stroke. 1999;30:1687-1694.)
© 1999 American Heart Association, Inc.


Original Contributions

Pharmacological Inhibition of the Na+/Ca2+ Exchanger Enhances Depolarizations Induced by Oxygen/Glucose Deprivation but Not Responses to Excitatory Amino Acids in Rat Striatal Neurons

Paolo Calabresi, MD; Girolama A. Marfia, MD; Salvatore Amoroso, MD; Antonio Pisani, MD Giorgio Bernardi, MD

From Clinica Neurologica, Dipartimento di Neuroscienze, Università Tor Vergata (P.C., G.A.M., A.P., G.B.), and IRCCS Ospedale Santa Lucia (P.C., G.B.), Rome, and Dipartimento di Neuroscienze, Università Federico II (S.A.), Naples, Italy.

Correspondence to Paolo Calabresi, Clinica Neurologica, Dipartimento di Neuroscienze, Università "Tor Vergata," via di Tor Vergata 135, 00133, Rome, Italy. E-mail calabre{at}uniroma2.it


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
Background and Purpose—Neuronal Na+/Ca2+ exchanger plays a relevant role in maintaining intracellular Ca2+ and Na+ levels under physiological and pathological conditions. However, the role of this exchanger in excitotoxicity and ischemia-induced neuronal injury is still controversial and has never been studied in the same neuronal subtypes.

Methods—We investigated the effects of bepridil and 3',4'-dichlorobenzamil (DCB), 2 blockers of the Na+/Ca2+ exchanger, in rat striatal spiny neurons by utilizing intracellular recordings in brain slice preparations to compare the action of these drugs on the membrane potential changes induced either by oxygen and glucose deprivation (OGD) or by excitatory amino acids (EAAs).

Results—Bepridil (3 to 100 µmol/L) and DCB (3 to 100 µmol/L) caused a dose-dependent enhancement of the OGD-induced depolarization measured in striatal neurons. The EC50 values for these effects were 31 µmol/L and 29 µmol/L, respectively. At these concentrations neither bepridil nor DCB altered the resting membrane properties of the recorded cells (membrane potential, input resistance, and current-voltage relationship). The effects of bepridil and DCB on the OGD-induced membrane depolarization persisted in the presence of D-2-amino-5-phosphonovalerate (50 µmol/L) plus 6-cyano-7-nitroquinoxaline-2,3-dione (20 µmol/L), which suggests that they were not mediated by an enhanced release of EAAs. Neither tetrodotoxin (1 µmol/L) nor nifedipine (10 µmol/L) affect the actions of these 2 blockers of the Na+/Ca2+ exchanger, which indicates that voltage-dependent Na+ channels and L-type Ca2+ channels were not involved in the enhancement of the OGD-induced depolarization. Conversely, the OGD-induced membrane depolarization was not altered by 5-(N,N-hexamethylene) amiloride (1 to 3 µmol/L), an inhibitor of the Na+/H+ exchanger, which suggests that this antiporter did not play a prominent role in the OGD-induced membrane depolarization recorded from striatal neurons. Bepridil (3 to 100 µmol/L) and DCB (3 to 100 µmol/L) did not modify the amplitude of the excitatory postsynaptic potentials evoked by cortical stimulation. Moreover, these blockers did not affect membrane depolarizations caused by brief applications of glutamate (0.3 to 1 mmol/L), AMPA (0.3 to 1 µmol/L), and NMDA (10 to 30 µmol/L).

Conclusions—These results provide pharmacological evidence that the activation of the Na+/Ca2+ exchanger exerts a protective role during the early phase of OGD in striatal neurons, although it does not shape the amplitude and the duration of the electrophysiological responses of these cells to EAA.


Key Words: bepridil • 3,4-dichlorobenzamil • excitatory amino acids • ischemia • sodium-hydrogen antiporter • synaptic transmission • rats


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
An important event that occurs during ischemia is the loss of ionic homeostasis.1 A long-lasting disruption of ionic gradients causes permanent cell injury. Accordingly, a major hypothesis concerning the mechanisms underlying neuronal injury after energy deprivation postulates that an increase in intracellular Ca2+ represents the critical event to trigger the cascade of processes leading to cell death.2 Various experimental findings have also stressed the important role of Na+ in the generation of cell damage induced by energy deprivation. Hypoxia-induced membrane depolarization is markedly attenuated by the removal of extracellular Na+ in various central neurons.3 4 Moreover, it has been reported that intracellular Na+ levels increase during anoxia and ischemia.5 6 A potential source of both Ca2+ and Na+ rise during ischemia is represented by the activation of ionotropic glutamate receptors, because an increased release of glutamate has been observed during both in vitro anoxia7 and in vivo ischemia.8 Neuronal Na+/Ca2+ exchanger may also play an important role in maintaining intracellular Ca2+ and Na+ levels in normal and pathological states.9 Under physiological conditions, Na+/Ca2+ exchanger transports Na+ in and Ca2+ out (forward mode).10 Membrane depolarizations induced either by ischemia or by excessive activation of excitatory amino acid (EAA) receptors may favor the reverse operation of the exchanger, moving Ca2+ in and Na+ out (reverse mode).11 The role of the Na+/Ca2+ exchanger in excitotoxicity and ischemia-induced neuronal injury is, however, still controversial. It has been reported that Na+/Ca2+ exchanger blockers are effective in protection against anoxic damage in the white matter.12 Conversely, Amoroso et al13 demonstrated that the blockade of the Na+/Ca2+ exchanger enhanced hypoxia-induced LDH release in glioma cells, providing pharmacological evidence that the activation of the Na+/Ca2+ exchanger plays a protective role during energy failure. Glutamate-induced increase in intracellular Na+ may also stimulate the reverse operation of the exchanger, increasing intracellular Ca2+ overload and potentiating injury.14 On the other hand, it has been shown15 that inhibition of the Na+/Ca2+ exchanger enhances delayed neuronal death elicited by glutamate in cerebellar granule cells cultures, which suggests a neuroprotective function of this exchanger during excitotoxicity.

In this work, therefore, we sought to further elucidate the possible modulatory role of Na+/Ca2+ exchanger during combined oxygen and glucose deprivation (OGD) and during the action of EAAs in striatal spiny neurons, a neuronal subtype that is particularly vulnerable both to energy deprivation and excitotoxicity.4 16 17 18 For this reason, we have tested the effects of bepridil12 14 19 20 21 and 3',4'-dichlorobenzamil (DCB),22 23 24 25 2 inhibitors of this exchanger, on the membrane depolarization induced by OGD in striatal spiny neurons intracellularly recorded from a brain slice preparation. Thus, we have compared these effects with those observed after blockade of Na+/Ca2+ exchanger during membrane depolarizations caused either by endogenous glutamate or by exogenous applications of EAA agonists.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
Preparation and Maintenance of the Slices
Male Wistar rats (Morini, Italy; 150 to 250 g) were used. The preparation and maintenance of coronal slices have been described previously4 17 18 and followed the institutional guidelines. Briefly, animals were anesthetized with ether and killed by cervical dislocation; corticostriatal coronal slices (200 to 300 µm) were then prepared from tissue blocks of the brain with the use of a Vibratome. A single slice was transferred to a recording chamber and submerged in a continuously flowing Krebs solution (35°C, 2 to 3 mL/min) gassed with 95% O2–5% CO2. To study OGD in striatal neurons, slices were deprived of glucose by removing glucose totally from the perfusate and by adding sucrose to balance the osmolarity. This solution was gassed with a mixture of 95% N2–5% CO2 instead of the normal gas mixture. In some experiments the osmolarity was balanced by increasing the NaCl concentration.26 Because experiments performed by use of these different procedures to replace glucose gave similar results, all the data were pooled together. Ischemic solutions entered the recording chamber no later then 20 seconds after turning a 3-way tap.

Recording Technique
In most of the experiments the intracellular recording electrodes were filled with 2 mol/L KCl (30 to 60 M{Omega}). An Axoclamp 2A amplifier (Axon Instruments) was used for intracellular recordings. Traces were displayed on an oscilloscope and stored on a digital system. For synaptic stimulation, bipolar electrodes were used. These stimulating electrodes were located either in the cortical areas close to the recording electrode or in the white matter between the cortex and the striatum to activate corticostriatal fibers. In some experiments biocytin (Sigma) was used in the intracellular electrode to stain the neurons. In these cases, biocytin at concentrations of 2% to 4% was added to a 0.5 mol/L-KCl pipette solution. Slices containing neurons stained with biocytin were fixed in paraformaldehyde (in 0.1 mol/L phosphate buffer at pH 7.4) overnight and processed according to published protocols.27

Data Analysis and Drug Applications
Quantitative data on changes of membrane depolarization were usually expressed as a percentage of the control value. Values given in the text and in the figures are mean±SEM of changes in the respective cell populations. The Student t test (for paired and unpaired observations) was used to compare the means. The characteristics of action potentials and of current-voltage curves in different experimental conditions were studied with use of a fast chart recorder and a digital system (Nicolet System 400; Benchtop Waveform Acquisition System, Sekonic). To calculate the area of the depolarization caused either by the application of the ischemic medium or by the application of EAAs, data were displayed on a high-gain strip-chart recorder (Gould RS 3400) and the area was calculated by the use of a digital planimeter. Responses that did not show any tendency to recovery after the offset of OGD or EAA application were discarded from the statistics. Drugs were administered by dissolving them to the desired final concentration in the saline and by switching the perfusion from control saline to drug-containing saline. 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX) was from Tocris. D-2-Amino-5-phosphonovalerate (D-APV), bepridil, and tetrodotoxin (TTX) were from Sigma. Nifedipine was from RBI. DCB and 5-(N,N-hexamethylene) amiloride were from E.J. Cragoe, Jr (Nacogdoches, Tex).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
Electrophysiological Properties of the Recorded Neurons
Conventional sharp-microelectrode intracellular recordings were obtained from 81 electrophysiologically identified "principal" spiny cells. The main characteristics of these cells have been described in detail previously both in vivo28 and in vitro.4 17 These cells had high resting membrane potential (-84±5 mV), relatively low apparent input resistance (38±8 M{Omega}) when measured at the resting potentials from the amplitude of small (<10 mV) hyperpolarizing electrotonic pulses, action potentials of short duration (1.1±0.3 ms), and high amplitude (102±4 mV). They were silent at rest and showed membrane rectification and tonic firing activity during depolarizing current pulses. In 22 of the 81 recorded spiny neurons, the electrophysiological identification was confirmed by a morphological analysis obtained by use of biocytin staining (data not shown).

Effect of Bepridil and DCB on the OGD-Induced Membrane Depolarization
OGD induced a membrane depolarization in all the recorded cells. The amplitude and the duration of the OGD-induced membrane depolarization was dependent on the time of exposure to the ischemic medium.29 As we have previously reported for hypoxia4 and aglycemia,17 this electrophysiological event was associated to a decreased input resistance (n=10, data not shown).29 Moreover, we found that the time course of the ischemic depolarization was much faster than those observed for hypoxia and aglycemia alone.4 17 In fact, a brief period (90 seconds) of OGD produced a significant membrane depolarization in the large majority of the recorded neurons (65 of 70 cells) whereas similar periods of aglycemia and hypoxia alone induced either no effect or much smaller changes of the membrane potential. In the remaining 5 striatal neurons, longer periods (2 to 3 minutes) of OGD were required to produce the membrane depolarization. To study the possible modulatory role of the Na+/Ca2+ exchanger on the ischemic depolarization, we applied bepridil, a blocker of this exchanger, 5 to 10 minutes before the brief ischemic exposure. In all the experiments using either bepridil or other pharmacological blockers, at least 2 control ischemic responses were obtained. Only neurons showing constant control responses to OGD were considered for further pharmacological analysis. Bepridil enhanced in a dose-dependent manner (10 to 100 µmol/L, n=30) the OGD-induced membrane depolarization with an EC50 of 31 µmol/L (Figure 1Down). We also tested whether DCB, a more specific blocker of the Na+/Ca2+ exchanger, could mimic the electrophysiological effect obtained with bepridil. As shown in Figure 2Down, DCB also increased in a dose-dependent manner (10 to 100 µmol/L, n=25) the ischemic depolarization with an EC50 of 29 µmol/L. We also investigated the possibility that bepridil and DCB altered the resting membrane properties of the recorded cells. At the doses used in the present study, neither bepridil (n=30) nor DCB (n=25) altered resting membrane potential, input resistance, and current-voltage relationship in the subthreshold range (Figure 3Down).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 1. Bepridil enhances in a dose-dependent manner the OGD-induced membrane depolarization recorded from striatal spiny neurons. A, The traces show the OGD-induced membrane depolarization under control condition (a) and in the presence of bepridil at different concentrations (b, 10 µmol/L; c, 30 µmol/L; and d, 100 µmol/L). The oxygen and glucose deprivation was applied for the period indicated by the black bar. The dotted line indicates the resting membrane potential (-85 mV), which remained constant throughout the experiment. Calibrations reported in panel d apply also to a, b, and c. B, Dose-response curve for the bepridil-induced increase of the area of the ischemic depolarization expressed as percentage of control (see "Materials and Methods" for further details). Each data point was obtained from at least 5 single experiments.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. DCB enhances in a dose-dependent manner the OGD-induced membrane depolarization recorded from striatal spiny neurons. A, The traces show the OGD-induced membrane depolarization under control condition (a) and in the presence of DCB at different concentrations (b, 10 µmol/L; c, 30 µmol/L; and d, 100 µmol/L). The oxygen and glucose deprivation was applied for the period indicated by the black bar. The dotted line indicates the resting membrane potential (RMP=-87 mV), which remained constant throughout the experiment. Calibrations reported in panel d apply also to a, b, and c. B, Dose-response curve for the DCB-induced increase of the area of the ischemic depolarization expressed as percentage of control (see "Materials and Methods" for further details). Each data point was obtained from at least 4 single experiments.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 3. Bepridil and DCB do not alter the current-voltage relationship of striatal spiny neurons under control conditions. Plots in A and B show the lack of effects of bepridil and DCB, respectively, on the current-voltage relationship of 2 striatal spiny cells. The plots were obtained from voltage-clamp experiments by holding the cells at –85 mV and applying positive and negative voltage steps of progressively increasing amplitudes (duration 0.5 to 3 seconds).

Effects of Bepridil and DCB Are Not Affected by Antagonists of Excitatory Amino Acids, TTX, and Ca2+ Channel Blockers
It has been reported that bepridil might produce effects other than the blockade of the Na+/Ca2+ exchanger. In particular, it has recently been shown30 that bepridil modulates NMDA currents in rat hippocampal neurons. Moreover, bepridil is able to enhance the release of EAAs induced by energy deprivation in hippocampal slices.7 For this reason, it was crucial to test (1) the possible involvement of an increased release of EAAs in the facilitatory effects of bepridil and DCB on the OGD-induced membrane depolarization and (2) the possibility that the pharmacological effects of these blockers were due to a postsynaptic modulation of neuronal responses to EAAs released during OGD. To address these issues, we incubated the slices in the presence of 50 µmol/L APV plus 20 µmol/L CNQX, which antagonize NMDA- and AMPA-like glutamate receptors, respectively. This pharmacological treatment affected neither the membrane depolarization induced by OGD (n=7, data not shown) nor the facilitatory action of bepridil (n=4, Figures 4ADown and 5Down) and DCB (n=4, Figure 5Down). Bepridil may also have a direct effect on voltage-dependent Na+ channels. Thus, we investigated whether TTX, a Na+ channel blocker, affected the effects of bepridil and DCB. TTX did not alter the OGD-induced membrane depolarization (n=3, data not shown) or the pharmacological effects on OGD produced by bepridil (n=4, Figures 4BDown and 5Down) and DCB (n=4, Figure 5Down). Furthermore, because it has been reported that bepridil modulates L-type Ca2+ channels, we studied the pharmacological action of bepridil and DCB in the presence of 10 µmol/L nifedipine, a blocker of L-type Ca2+ channels. Also, this channel blocker failed to affect the OGD-induced depolarization (n=3, data not shown) and the actions of bepridil (n=4, Figures 4CDown and 5Down) and DCB (n=4, Figure 5Down).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. The pharmacological action of bepridil is not affected by the blockade of ionotropic glutamate receptors, of voltage-dependent Na+ channels, or of L-type Ca2+ channels. A, The incubation of the slice in the presence of 50 µmol/L APV plus 20 µmol/L CNQX did not block the bepridil-induced increase of the ischemic depolarization recorded from a spiny neuron (a, control; b, 30 µmol/L bepridil) (RMP=-86 mV). B, The incubation of the slice in the presence of 1 µmol/L TTX did not block the bepridil-induced increase of the ischemic depolarization recorded from a spiny neuron (a, control; b, 30 µmol/L bepridil) (RMP=-88 mV). C, The incubation of the slice in the presence of 10 µmol/L nifedipine did not block the bepridil-induced increase of the ischemic depolarization recorded from a spiny neuron (a, control; b, 30 µmol/L bepridil) (RMP=-87 mV). Calibrations reported in C apply also to A and B.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 5. Lack of effect of various experimental conditions to block the pharmacological actions of bepridil and DCB. The graph shows that the increase of the area of the OGD-induced membrane depolarization produced either by bepridil or by DCB is not altered the blockade of ionotropic glutamate receptors (50 µmol/L APV plus 20 µmol/L CNQX), of voltage-dependent Na+ channels (1 µmol/L TTX), or of L-type Ca2+ channels (10 µmol/L nifedipine).

Lack of Effect of Bepridil and DCB on Responses to EAAs
To further investigate the possible interaction between the activity of the Na+/Ca2+ exchanger and the electrophysiological effects of EAAs on striatal neurons both at presynaptic and postsynaptic sites, we studied the effect of bepridil and DCB in various experimental conditions. First, we measured the effect of these blockers on the amplitude of EPSPs evoked by cortical stimulation. Neither bepridil (30 µmol/L, Figures 6ADown and E) nor DCB (30 µmol/L, data not shown) affected the amplitude of these synaptic potentials. Then, we tested a possible action of these 2 drugs on the membrane depolarizations induced by brief applications of glutamate (1 mmol/L, 10 to 20 seconds), AMPA (0.3 to 1 µmol/L, 30 to 60 seconds), and NMDA (10 to 30 µmol/L, 30 to 60 seconds). Neither bepridil (30 µmol/L, Figures 6BDown, C, D, and E) nor DCB (30 µmol/L, data not shown) were able to modify these membrane responses.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 6. Bepridil does not affect corticostriatal EPSPs and membrane depolarizations induced by brief applications of either glutamate or agonists of ionotropic glutamate receptors. A, The traces show that corticostriatal EPSP recorded from a striatal spiny neuron (a) was not affected by 30 µmol/L bepridil (b; RMP=-84 mV). B, Brief applications of exogenous glutamate (1 mmol/L) induced a membrane depolarization (a) that is not affected by 30 µmol/L bepridil (b; RMP=-86 mV). C, Brief applications of AMPA (1 µmol/L) induced a membrane depolarization (a) that is not affected by 30 µmol/L bepridil (b; RMP=-87 mV). D, Brief applications of NMDA (30 µmol/L) induced a membrane depolarization (a) that is not affected by 30 µmol/L bepridil (b; RMP=-85 mV). Calibrations reported in B apply also to C and D. E, The graph shows that the EPSP amplitude and the membrane depolarizations induced by glutamate, AMPA, and NMDA were not affected by 30 µmol/L bepridil.

Lack of Effect of HMA on the OGD-Induced Membrane Depolarization
It has been suggested that intracellular acidification which occurs during ischemia activates the Na+/H+ exchanger, resulting in Na+ loading. Pharmacological inhibition of the Na+/H+ exchanger has been reported to inhibit the rise in intracellular Na+ and to delay the rise in Ca2+ in cardiac myocytes.31 To evaluate the possible involvement of the Na+/H+ exchanger in our experimental model of in vitro ischemia, we investigated the effects of HMA, a blocker of this exchanger, on the OGD-induced membrane depolarization. HMA (1 to 3 µmol/L) did not affect this electrophysiological event in any of the tested neurons. In fact, the OGD-induced depolarization was not significantly altered by HMA (102±5%, n=10, P>0.05) (data not shown).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
down arrowIntroduction 
down arrowReferences 
 
The main finding of our study is that the pharmacological inhibition of Na+/Ca2+ exchanger enhances the OGD-induced membrane depolarization in striatal spiny neurons whereas it does not affect glutamate-mediated synaptic potentials and membrane responses to EAAs. Although the pharmacological data supporting this observation appear highly consistent, the interpretation of the mechanism involved in this facilitatory action is far from being obvious and requires an accurate consideration of the ionic mechanisms underlying the ischemic depolarization in striatal spiny neurons. We recently found that the OGD-induced membrane depolarization is associated with a rise in intracellular concentrations of both Na+ and Ca2+. However, the buffering of intracellular Ca2+ by injecting BAPTA, a Ca2+ chelator, via the recording pipette did not reduce the ischemic depolarization. On the contrary, the lowering of the extracellular Na+ concentration significantly reduced this event. Thus, we argued that Na+ influx plays a major role in the generation of this early electrical event. The source of this Na+ influx was not identified. In fact, neither the blockade of voltage-dependent Na+ channels by TTX nor the antagonism of the ionotropic glutamate receptors by CNQX and APV significantly altered the ischemic depolarization, which suggests that a TTX insensitive, nonselective cation conductance might play a role in this event.29

It has been shown that the Na+/Ca2+ exchanger becomes reversed during hypoxia,12 19 and there is a growing amount of literature on the role of this exchanger during energy deprivation in a variety of CNS tissue.7 32 Blockers of the Na+/Ca2+ exchanger afforded protection from anoxic injury in the rat optic nerve preparation.12 This protection was attributed, however, to a net reduction in intracellular Ca2+ due to the blockade of this exchanger. The authors argued that the anoxia-induced increase in intracellular Na+ concentration acts to reverse the driving force for the Na+/Ca2+ exchanger, thereby causing an increase in intracellular Ca2+. This increase caused neuronal injury and was inhibited by the blockade of the Na+/Ca2+ exchanger.

From our previous and current experiments, we propose a different interpretation of the role of this exchanger during OGD in spiny neurons. We suggest that the activation of the Na+/Ca2+ exchanger during the ischemic depolarization has a protective role, because we found that bepridil and DCB enhanced this electrophysiological event. Thus, we postulate that during OGD in striatal spiny neurons, as well as in optic nerve preparation, the rise in intracellular Na+ levels might force this exchanger to operate in a reverse mode (as a Na+ extruding system). However, in striatal spiny neurons, unlike in optic nerve preparation, the critical event for the OGD-induced injury is represented by the rise of intracellular Na+ rather than the intracellular increase of Ca2+. This conclusion contrasts with results from previous studies using other experimental models.33 In agreement with our findings, it has been recently reported that activation of the Na+/Ca2+ exchanger protects C6 glioma cells during chemical hypoxia.13 However, future studies in brain slices utilizing ion measurements of intracellular Ca2+ and Na+ are required to confirm this hypothesis. Unfortunately, at present, most of the drugs interfering with the activity of Na+/Ca2+ exchanger and Na+/H+ antiporter are amiloride derivatives, and their use is hampered by their autofluorescent properties.6 One should also consider the possibility that since glial cells are present in our preparation, they may play a role in the pharmacological effect we recorded from neuronal elements.

It has been shown that pharmacological inhibition of the Na+/Ca2+ exchanger enhances anoxia and glucopenia-induced release of EAAs in hippocampal slices.7 Thus, in the present study we have also addressed the possibility that the bepridil- and DCB-induced enhancement of the ischemic depolarization was due to an increased release of EAAs. The findings that these pharmacological effects were affected neither by TTX nor by antagonists of ionotropic glutamate receptors seems to rule out a presynaptic site of action of these drugs.

We have recently reported that L-type Ca2+ channels give a prominent contribution to both OGD-induced membrane depolarization and intracellular Ca2+ rise measured in cortical neurons.34 Thus, we have studied the possible involvement of these channels in the ischemic depolarization of striatal spiny neurons and in the facilitatory action of bepridil and DCB. The finding that nifedipine did not influence these latter parameters seems to exclude that L-type Ca2+ channels play a major role in the generation of this early ionic event and in its pharmacological modulation by blockers of Na+/Ca2+ exchanger.

We are aware that bepridil may cause effects other than inhibition of the Na+/Ca2+ exchanger.9 30 Thus, we have performed experiments with the amiloride derivative DCB, another inhibitor of the Na+/Ca2+ exchanger, and obtained similar results. The specificity of the effect of DCB on the Na+/Ca2+ activity was further supported by the lack of any effect on the ischemic depolarization exerted by HMA. This compound, although possessing a piperazine ring like DCB, is devoid of any inhibitory properties on the Na+/Ca2+ exchanger.35 In addition, because HMA has, at concentration of 1 µmol/L, Na+/H+ antiporter inhibitory properties,35 its failure to alter the ischemic depolarization seems to suggest that this antiporter is not involved in the mechanisms leading to this ionic event. It has been reported that bepridil and DCB might block K+ channels.36 Thus, it is possible that an interference of these compounds with K+ conductances might alter the OGD-induced depolarization. However, the latter possibility is unlikely, because bepridil and DCB at the concentrations used in this study do not affect the current-voltage relationship of the recorded cells.

The present study represents the first experimental attempt to compare the role of the Na+/Ca2+ exchanger during OGD and during the activation of ionotropic glutamate receptors in the same neuronal subtype. In hippocampal neurons, Ca2+ extrusion via the Na+/Ca2+ exchanger apparently plays an important role in the protection against neuronal excitotoxicity.37 Similar evidence for a protective role for the Na+/Ca2+ exchanger in glutamate neurotoxicity has also been obtained from studies in cerebellar granule cells.15 In these cells, pharmacological inhibitors of the exchanger strongly enhance glutamate-induced neuronal death. Another study, in the same neuronal subtypes, provided additional evidence in support of this hypothesis. Kiedrowski and colleagues14 demonstrated that glutamate pulses exhibit higher neurotoxicity than potassium pulses because of their greater capability to increase the intracellular Na+ concentration, which in turn impairs Ca2+ extrusion via the Na+/Ca2+ exchanger. In our experimental model we failed to detect a significant modulatory action of bepridil and DCB not only on the glutamate-mediated corticostriatal EPSPs whose amplitude and duration were much smaller than the ischemic depolarization, but also on the membrane responses induced by exogenous EAA agonists whose amplitude and duration mimicked the ischemic depolarization. Two explanations may account for this lack of effect. First, in our study we have evaluated the acute effect induced by EAAs (membrane depolarization) rather than the long-term morphological changes following excitotoxicity, which have been evaluated in most of the previous studies. It is possible that Ca2+ overload does not influence the acute EAA agonist–induced membrane depolarization while it plays a prominent role in the "delayed neuronal death." Second, under physiological conditions, the supply of ATP is not limited, and the Ca2+-ATPase would be capable of extruding most of the excess of Ca2+ admitted during the activation of ionotropic glutamate receptors. Moreover, the Na+/K+ ATP-dependent pump is able to provide an effective mechanism to limit excessive intracellular Na+ overload during the action of various EAAs.38 The activity of these 2 protective mechanisms is impaired during energy deprivation, because ATP production is dramatically reduced. Thus, in this physiopathological condition, the protective role of the Na+/Ca2+ exchanger operating in its reverse mode is unmasked. Finally, we would like to close this study with 2 notes of caution in the interpretation of the presented data. First, in our experimental model we have analyzed membrane depolarizations induced by OGD. It is commonly assumed that these depolarizations may ultimately lead to neuronal death; however, a morphological analysis of the tissue alterations induced by OGD in our model has not been performed. Second, our conclusions stands on in vitro data; future studies utilizing in vivo models of ischemia would be of great interest to further clarify the role of Na+/Ca2+ exchanger in this pathological event.


*    Acknowledgments
 
We wish to thank M. Tolu for the excellent technical assistance. This study was supported by a grant from Biomed Project to Dr Calabresi (BMH4-97-2215), a Telethon grant to Dr Calabresi (E. 729), and a MURST/CNR grant to Dr Bernardi (legge 95/95).

Received February 8, 1999; revision received April 14, 1999; accepted May 3, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
down arrowIntroduction 
down arrowReferences 
 
1. Martin RL, Lloyd HGE, Cowan AI. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci. 1994;17:251–257.[Medline] [Order article via Infotrieve]

2. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13:171–182.[Medline] [Order article via Infotrieve]

3. Friedman JE, Haddad GG. Removal of extracellular sodium prevents anoxia-induced injury in freshly dissociated rat CA1 hippocampal neurons. Brain Res. 1994;641:57–64.[Medline] [Order article via Infotrieve]

4. Calabresi P, Pisani A, Mercuri NB, Bernardi G. On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. Brain. 1995;118:1027–1038.[Abstract/Free Full Text]

5. Friedman JE, Haddad GG. Anoxia induces an increase in intracellular sodium in rat central neurons in vitro. Brain Res. 1994;663:329–334.[Medline] [Order article via Infotrieve]

6. Pisani A, Calabresi P, Tozzi A, Bernardi G, Knopfel. Early sodium elevations induced by combined oxygen and glucose deprivation in pyramidal cortical neurons. Eur J Neurosci. 1998;10:3572–3574.[Medline] [Order article via Infotrieve]

7. Amoroso S, Sensi S, Di Renzo G, Annunziato L. Inhibition of the Na+-Ca++ exchanger enhances anoxia and glucopenia-induced [3H]aspartate release in hippocampal slices. J Pharmacol Exp Ther. 1993;264:515–520.[Abstract/Free Full Text]

8. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevation of the extracellular concentration of glutamate and aspartate in the rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurosci. 1984;43:1369–1374.

9. Steffensen I, Stys PK. The Na+-Ca2+ exchanger in neurons and glial cells. Neuroscientist.. 1996;2:162–171.[Abstract/Free Full Text]

10. Sanchez-Armass S, Blaustein MP. Role of sodium-calcium exchange in regulation of intracellular calcium in nerve terminals. Am J Physiol. 1987;252:C595–603.[Abstract/Free Full Text]

11. Mullins LJ. A mechanism for Na/Ca transport. J Gen Physiol. 1977;70:681–695.[Abstract/Free Full Text]

12. Stys PK, Waxman SG, Ransom BR. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na+-Ca2+ exchanger. J Neurosci. 1992;12:430–439.[Abstract]

13. Amoroso S, De Maio M, Russo GM, Catalano A, Bassi A, Montagnani S, Di Renzo G, Annunziato L. Pharmacological evidence that the activation of the Na+-Ca2+ exchanger protects C6 glioma cells during chemical hypoxia. Br J Pharmacol. 1997;121:303–309.[Medline] [Order article via Infotrieve]

14. Kiedrowski L, Brooker G, Costa E, Wroblewski JT. Glutamate impairs neuronal calcium extrusion while reducing sodium gradient. Neuron. 1994;12:295–300.[Medline] [Order article via Infotrieve]

15. Andreeva N, Khodorov B, Stelmashook E, Cragoe E, Victorov I. Inhibition of Na+/Ca2+ exchange enhances delayed neuronal death elicited by glutamate in cerebellar granule cell cultures. Brain Res. 1991;548:322–325.[Medline] [Order article via Infotrieve]

16. Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res. 1985;63:29–37.[Medline] [Order article via Infotrieve]

17. Calabresi P, Magarinos Ascone C, Centonze D, Pisani A, Sancesario G, D'Angelo V, Bernardi G. Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large spiny interneurons. J Neurosci. 1997;17:1940–1949.[Abstract/Free Full Text]

18. Calabresi P, Centonze D, Pisani A, Sancesario G, Gubellini P, Marfia GA, Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Ann Neurol. 1998;43:586–597.[Medline] [Order article via Infotrieve]

19. Waxman SG, Ransom BR, Stys PK. Non-synaptic mechanisms of calcium-mediated injury in CNS white matter. Trends Neurosci. 1991;14:461–468.[Medline] [Order article via Infotrieve]

20. Agrawal SK, Fehlings MG. Mechanisms of secondary injury to spinal cord axons in vitro: role of Na+, Na+-K+-ATPase, the Na+-H+ exchanger, and the Na+-Ca2+ exchanger. J Neurosci. 1996;16:545–552.[Abstract/Free Full Text]

21. Lehning EJ, Doshi R, Isaksson N, Stys PK, LoPachin RM Jr. Mechanisms of injury-induced calcium entry into peripheral nerve myelinated axons: role of reverse sodium-calcium exchange. J Neurochem. 1996;66:493–500.[Medline] [Order article via Infotrieve]

22. Wacholtz MC, Cragoe EJ Jr, Lipsky PE. Delineation of the role of a Na+/Ca2+ exchanger in regulating intracellular Ca2+ in T cells. Cell Immunol. 1993;147:95–109.[Medline] [Order article via Infotrieve]

23. Li L, van Breemen C. Na+-Ca2+ exchange in intact endothelium of rabbit cardiac valve. Circ Res. 1995;76:396–404.[Abstract/Free Full Text]

24. Monroe JJ, Tashjian AH Jr. Actions of palytoxin on Na+ and Ca2+ homeostasis in human osteoblast-like Saos-2 cells. Am J Physiol. 1995;269:C582–C589.[Abstract/Free Full Text]

25. Shiraga M, Tomiyama Y, Honda S, Kashiwagi H, Kosugi S, Handa M, Ikeda Y, Kanakura Y, Kurata Y, Matsuzawa Y. Affinity modulation of the platelet integrin alpha IIb beta 3 by alpha-chymotrypsin: a possible role for Na+/Ca2+ exchanger. Blood. 1996;88:2594–2602.[Abstract/Free Full Text]

26. Jiang Z-C, Haddad GG. Differential responses of neocortical neurons to glucose and/or O2 deprivation in human and rat. J Neurophysiol. 1992;68:2165–2173.[Abstract/Free Full Text]

27. Horikawa H, Armstrong WE. A versatile means of intracellular labelling: injection of biocytin and its detection with avidin conjugates. J Neurosci Methods. 1988;25:1–11.[Medline] [Order article via Infotrieve]

28. Calabresi P, Mercuri NB, Stefani A, Bernardi G. Synaptic and intrinsic control of membrane excitability of neostriatal neurons. I. An in vivo analysis. J Neurophysiol. 1990;63:651–662.[Abstract/Free Full Text]

29. Calabresi P, Marfia GA, Centonze D, Pisani A, Bernardi G. Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in striatal spiny neurons. Stroke. 1999;30:171–179.[Abstract/Free Full Text]

30. Sobolevsky A, Koshelev S, Khodorov BI. Bepridil-induced blockade of NMDA channels in rat hippocampal neurons. Neuropharmacology. 1997;36:319–324.[Medline] [Order article via Infotrieve]

31. Anderson SE, Murphy E, Steenbergen C, London R, Cala P. Na-H exchange in myocardium: effects of hypoxia and acidification on Na and Ca. Am J Physiol. 1990;259:C940–C948.[Abstract/Free Full Text]

32. Chidekel AS, Chow EJ, Friedman JE, Haddad GG. The role of Na+-dependent exchangers in anoxia-induced injury in rat neocortical neuronal culture. Am J Resp Crit Care Med. 1996;512:A639. Abstract.

33. Farooqui AA, Horrocks LA. Excitatory amino acid receptors, neuronal membrane phospholipid metabolism and neurological disorders. Brain Res Rev. 1991;16:171–191.[Medline] [Order article via Infotrieve]

34. Pisani A, Calabresi P, Tozzi A, D'Angelo V, Bernardi G. L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons. Stroke. 1998;29:196–201.[Abstract/Free Full Text]

35. Simchowitz L, Cragoe JR. Inhibition of chemotactic factor-activated Na+-H+ exchange in human neutrophils by analogs of amiloride: structure-activity relationship in the amiloride series. Mol Pharmacol. 1986;30:112–20.[Abstract]

36. Matsuda T, Takuma K, Baba A. Na+-Ca2+ exchanger: physiology and pharmacology. Jpn J Pharmacol. 1997;74:1–20.[Medline] [Order article via Infotrieve]

37. Mattson MP, Guthrie PB, Kater SB. A role for Na+-dependent Ca++ extrusion in protection against neuronal excitotoxicity. FASEB J. 1989;3:2519–2526.[Abstract]

38. Calabresi P, De Murtas M, Pisani A, Stefani A, Sancesario G, Mercuri NB, Bernardi G. Vulnerability of medium spiny striatal neurons to glutamate: role of Na+/K+ ATPase. Eur J Neurosci. 1995;7:1674–1683.[Medline] [Order article via Infotrieve]

Editorial Comment

Patricia D. Hurn, PhD, Guest Editor

Anesthesiology/Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Maryland


*    Introduction 
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
up arrowReferences
*Introduction 
down arrowReferences 
 
Increased intracellular calcium (Ca2+) has been widely demonstrated to be a focal point in cell death cascades for many types of neurons and supporting cells. The relative significance of increased intracellular sodium supporting cells. The relative significance of increased intracellular sodium (Na+) in neuronal survival after anoxic depolarization and energy failure has not been as well studied. If elevated intracellular Na+ also contributes to neuronal demise, what are the sources of Na+ influx and which extrusion mechanisms dominate in the strategy for control of transmembrane ionic gradients? When ATP production is persistently inadequate, energy dependent Na+/K+ pumps and Ca2+ ATPase unlikely defenders of cation homeostasis. Therefore, the membrane Na+/Ca2+ exchanger, which in physiological forward mode transports Na+ in and Ca2+ out of the cell, may become instrumental in reducing anoxic, or exacerbating, damage in central neurons. Given that the exchanger can be forced into reverse mode, moving Ca2+ into the neuron1 2 3 and that exchange inhibitors can improve damage in several experimental paradigms and tissue types, it has been argued that the Na+/Ca2+ exchanger potentiates anoxic, hypoxic, and excitotoxic injury (for reviews, see References 4 and 5). This is the central and controversial issue addressed by the preceding paper. Using a well-established model of oxygen/glucose deprivation (OGD) in brain slices, the authors provide new information about the role of the Na+/Ca2+ exchanger in striatal spiny neurons, which are vulnerable to energy depletion and to glutamate excess. They clearly show that inhibitory agents which block the exchanger enhanced OGD-induced depolarization, suggesting a protective role. Moreover, the enhanced depolarization was specific to OGD and was not observed when neurons were challenged at ionotropic glutamate receptor activation in varying forms and doses. Interactions with other key regulators of Na+ and Ca2+ were reasonably excluded, including voltage-dependent Na+ channels, L-type Ca2+ channels, and the Na+/H+ antiporter. Therefore, the importance of Na+/Ca2+ exchange in energy failure is not trivial. It should be noted that the evidence provided is exclusively pharmacological and assumes reasonable specificity and efficacy of the antagonists employed. The latter point was not demonstrated; however, 2 different agents were used with quite similar results. From a clinical perspective, what remains to be shown is morphological evidence of protection in this neuronal subtype or that enhanced Na+/Ca2+ exchange is beneficial to injured or recovering cells.

Received February 8, 1999; revision received April 14, 1999; accepted May 3, 1999.


*    References 
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
up arrowReferences
up arrowIntroduction 
*References 
 
1. Yu SP and Choi DW. Na+-Ca2+ exchange currents in cortical neurons: concomitant forward and reverse operation and effect of glutamate. Eur J Neuroscience.. 1997;9:1273–81.[Medline] [Order article via Infotrieve]

2. Hoyt KR, Arden SR, Aizenman E, Reynolds IJ. Reverse Na+/Ca2+ exchange contributes to glutamate-induced intracellular Ca2+ concentration increases in cultured rat forebrain neurons. Mol Pharmacol.. 1998;53:742–9.[Abstract/Free Full Text]

3. Schroeder UH, Breder J, Sabelhaus CF, Reymann KG. The novel Na+/Ca2+ exchange inhibitor KB-R7943 protects CA1 neurons in rat hippocampal slices against hypoxic/hypoglycemic injury. Neuropharmacol.. 1999;38:319–21.[Medline] [Order article via Infotrieve]

4. DiPolo R, Beauge L. Metabolic pathways in the regulation of invertebrate and vertebrate Na+/Ca2+ exchange. Biochim Biophys Acta.. 1999;1422:57–71.[Medline] [Order article via Infotrieve]

5. Stys PK. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J Cereb Blood Flow Metab.. 1998;18:2–25.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
StrokeHome page
A. Tortiglione, B. Picconi, I. Barone, D. Centonze, S. Rossi, C. Costa, M. Di Filippo, A. Tozzi, M. Tantucci, G. Bernardi, et al.
Na+/Ca2+ Exchanger Maintains Ionic Homeostasis in the Peri-Infarct Area
Stroke, May 1, 2007; 38(5): 1614 - 1620.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. Annunziato, G. Pignataro, and G. F. Di Renzo
Pharmacology of Brain Na+/Ca2+ Exchanger: From Molecular Biology to Therapeutic Perspectives
Pharmacol. Rev., December 1, 2004; 56(4): 633 - 654.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Zhang, M. Cheng, and S. K. Chintala
Kainic Acid-Mediated Upregulation of Matrix Metalloproteinase-9 Promotes Retinal Degeneration
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2374 - 2383.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
P. Calabresi, E. Saulle, D. Centonze, A. Pisani, G. A. Marfia, and G. Bernardi
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability
Brain, April 1, 2002; 125(4): 844 - 860.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. Centonze, A. Pisani, P. Bonsi, P. Giacomini, G. Bernardi, and P. Calabresi
Stimulation of Nitric Oxide-cGMP Pathway Excites Striatal Cholinergic Interneurons via Protein Kinase G Activation
J. Neurosci., February 15, 2001; 21(4): 1393 - 1400.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calabresi, P.
Right arrow Articles by Hurn, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Calabresi, P.
Right arrow Articles by Hurn, P. D.
Related Collections
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Embolic stroke
Right arrow Other Stroke Treatment - Medical